At Moehs Group we are very committed to caring for our planet and our activity strictly complies with each and every one of our commitments. With regard to our project to mitigate greenhouse gases, we have expanded the number of photovoltaic installations during the first semester of 2024. Between January and June 2024, the current […]

The Administration Board of the Centro para el Desarrollo Tecnológico y la Innovación, E.P.E (CDTI), has approved 2 important grants for Moehs Group: ABROCITINIB: development of a new chemical synthesis method of a janus kinase inhibitor active ingredient for the treatment of atopic dermatitis. VERICIGUAT: the objective is to develop a new method of chemical

The traffic department of Moehs Group has had the opportunity to visit Emirates facilities at Barcelona Airport where they saw, first hand, how the air cargo loading process is carried out. Thank you very much Emirates for allowing us to be part of this logistics process and show us the great daily work that you

From Moehs Group we would like to announce our incorporation as a member of the CataloniaBio & HealthTech platform. An entity that represents companies in the biomedicine and health sector in Catalonia, with the aim of defending and promoting the interests of the business fabric of the sector.      

We are very proud to share the results obtained on the reduction of our carbon footprint! Once again, at Moehs Group, we continue striving and working hard to fulfil our commitment to respect the environment. In this last calculation of 2023, carried out by Cecot, we have achieved lower emissions compared to the previous period,

On Sunday 7th April Oxfam Intermón organized the TRAILWALKER walk, the biggest sporting and solidarity challenge that consists of covering 100 km in 32 hours, 55 km in 16 hours, or 10 km in 4 hours. The goal? To turn each participant’s kilometres into water. With the donations, they respond to the poverty caused by

Moehs Group participates in the S3 Indústria project together with teachers from the Chemistry department of the Institutes Federica Montseny (Burjassot, Valencia) and Dr. Peset Aleixandre (Paterna, Valencia). With this project, thanks to the #ConvocatoriaDualiza of CaixaBank, it aims to generate new learning situations on the subject of air pollution. The first day of the

We are proud to announce that the Moehs Research and Development project regarding nitroso-Sitagliptin impurity has been published by the scientific Journal of Separation Science Plus. This a very important step if we take into consideration that this impurity is classified as a potentially genotoxic impurity. The pharma industry is still facing the nitrosamines nightmare.

Moehs Group participated in CPHI Barcelona, the great European event of the pharmaceutical sector. At our stand 6B40 in Hall 6, our team received hundreds of visitors interested in our services and shared space with other professionals of the sector. Thanks to all the organization for this magnificent event.  

Moehs Group has just received Japanese patent JP7327736 for the API Edoxaban. This document is related to an improving method to produce EDOXABAN allowing us to strengthen our position as an API manufacturer worldwide.